Stocks and Investing
Stocks and Investing
Mon, April 13, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Navin Jacob Maintained (ABBV) at Strong Buy with Decreased Target to $96 on, Apr 13th, 2020
Navin Jacob of UBS, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Decreased Target from $106 to $96 on, Apr 13th, 2020.
Navin has made no other calls on ABBV in the last 4 months.
There are 4 other peers that have a rating on ABBV. Out of the 4 peers that are also analyzing ABBV, 2 agree with Navin's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Randall Stanicky of "RBC Capital" Maintained at Hold with Decreased Target to $79 on, Tuesday, March 24th, 2020
- Justin Smith of "Societe Generale" Downgraded from Strong Buy to Hold on, Monday, March 23rd, 2020
These are the ratings of the 2 analyists that currently disagree with Navin
- Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $105 on, Tuesday, February 18th, 2020
- Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $104 on, Monday, February 10th, 2020